When: $261-$263 retest on RSI divergence (price lower-low, RSI higher-low above 30) at lower Bollinger Band

Then: Partial re-engagement

When: Post-Q3 2026 earnings showing positive US comparable sales growth (>+1%) and margin stabilization

Then: Full re-engagement on fundamental confirmation

HOLD (trim to 60-70% benchmark weight)

• Dividend yield of 2.73% is backed by $6.26B in trailing twelve month free cash flow against $5.12B in annual dividend payments, with ~1.2x FCF coverage — not a yield trap
• 27 percentage point underperformance is multiple compression from rate regime change plus soft execution, not structural impairment; MCD has 0.42 beta and has recovered from similar drawdowns in 2015, 2018, 2022
• Q2 2026 revenue was $7.10B (up from $6.84B YoY), EPS $3.32 (up from $3.14), operating margin at 46.5%, net income $2.36B — business growing, not in free-fall
• Aggressive analyst's $221 price target (17x multiple on $13 EPS) is a worst-case presented as base case; bear scenario technical target is $245-250
• Aggressive analyst's collar ($290 calls sold against $245 puts) concedes ~$25 of potential recovery for ~$20 of downside protection with meaningful net cost drag
• Polymarket shows 85% probability of zero Fed rate cuts but only 8% US recession probability by end of 2026, supporting soft-landing mean reversion
• Q2 miss was execution failure on value menus with tepid comps and stable margins, not structural demand destruction from lower-income consumer stress
• Waiting for 50-day SMA reclaim at $273.48 before acting risks missed execution or trimming into dead-cat bounce; trader's current trim is better calibrated
• Conservative supports: trim to 60-70% benchmark weight, no new buys at $265.53, optional collar/put hedge, $258 close stop, re-engage on confirmed 50-day SMA reclaim with positive momentum

→ vs aggressive: Dividend yield of 2.73% on $6.26B FCF with 1.2x payout coverage is not a yield trap; aggressive analyst conflates yield with valuation

→ vs aggressive: 27 percentage point underperformance reflects multiple compression on soft quarter, not structural impairment; 0.42 beta indicates defensive compounder that has recovered from similar drawdowns before

→ vs aggressive: $221 bear case target (17x multiple on $13 EPS) is not supported by technical report's $245-250 downside target; aggressive analyst extrapolates too dramatically

→ vs aggressive: Collar strategy caps upside at $290, concedes ~$25 recovery for $20 protection, imposes net cost drag, and prevents participation in positive Q3 surprise — turns 60-90 day trim into structural underweight

→ vs aggressive: Soft-landing base case (8% recession probability) supports defensive mean reversion; aggressive analyst prices in rate headwind but ignores mean-reversion tailwind

→ vs aggressive: Q2 weakness was execution miss on value menus with tepid comps and stable margins, not consumer demand destruction — treating as latter causes whipsaw

→ vs neutral: Waiting for 50-day SMA reclaim at $273.48 before trimming risks poor execution; better to trim at current $265 level per trader's plan than wait for technical confirmation that may not come cleanly

Trim to 50-65% of benchmark weight depending on portfolio context; use $255 stop; allow partial re-entry at $261-$263 on RSI divergence; skip collar; 12-week target $250-$258

• Aggressive $221 worst-case constructed by stacking two bearish assumptions (forward EPS cut to $13 AND multiple compression to 17x simultaneously)
• MCD fundamentals still strong: $6.26B trailing FCF, $5.12B annual dividends, 46.5% operating margins, Q2 EPS beat YoY
• Beta of 0.42 indicates defensive franchise, not cyclically-impaired discretionary
• Trader's collar at current prices concedes ~$25 recovery potential for ~$20 downside protection — overpriced given implied volatility
• Conservative $273.48 50-day SMA reclaim may never come cleanly given macro headwinds (85% probability of zero Fed cuts in 2026, 30-year yield at 19-year high)
• Polymarket prices US recession at only 8% — supports soft landing but no multiple expansion catalyst visible
• MCD recovered after 2015, 2018, 2022 drawdowns but each case had Fed pivot or multiple expansion catalyst — that catalyst absent now
• $258 close stop too tight at only 1.3x daily ATR of $5.79 — normal price noise can trigger whipsaw
• July low at $264.95 likely provides first support; actual breakdown level closer to $250-$255 rather than $245
• Q3 earnings is the primary near-term catalyst; trim itself is the risk reduction, making explicit hedge optional

→ vs aggressive: Bear case on $221 worst-case not supported by data — $6.26B FCF against $5.12B dividends, 46.5% margins, and Q2 EPS beat YoY indicate compounder, not structural decline. 'Regime change' framing is categorical error on a defensive franchise.

→ vs aggressive: Collar strategy pre-commits to bearish view that hasn't been validated — conceded $25 recovery for $20 protection in 60-90 day window when MCD still generating $2.3B net income per quarter.

→ vs conservative: Called trader's plan 'sweet spot' without interrogating whether it is too cautious — doesn't push back on the same confirmation requirement for re-entry that the conservative criticizes in the neutral analyst.

→ vs conservative: Used 8% recession probability to argue for defensive mean reversion but ignored that mean reversion requires multiple expansion catalyst — in soft landing with no Fed cuts and elevated yields, defensive names can stay range-bound for extended periods.